R Göke1, A Göke, B Göke, W S El-Deiry, Y Chen. 1. Department of Molecular and Cellular Engineering, University of Pennsylvania School of Medicine, Philadelphia, Pa, USA. rgoeke@gmx.net
Abstract
BACKGROUND/AIMS: We investigated the effect of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist pioglitazone on growth and TRAIL-induced apoptosis in carcinoid cells. METHODS: Carcinoid cells were incubated without and with pioglitazone. Effects on growth were examined by cell count and cell cycle analysis. p21waf1/cip1 expression was determined by Western blotting. Cytotoxicity assay was performed by FACS analysis. RESULTS: Pioglitazone suppressed the growth and induced apoptosis of carcinoid cells. Additionally, pioglitazone significantly enhanced carcinoid cell death induced by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL). The enhancement of TRAIL-induced apoptosis was associated with an upregulation of cyclin-dependent kinase inhibitor p21waf1/cip1 in pioglitazone-treated carcinoid cells. Importantly, overexpression of p21waf1/cip1 in carcinoid cells by adenoviral gene transfer of p21 sensitized them to TRAIL-induced apoptosis. CONCLUSIONS: These results suggest that pioglitazone inhibits cell growth and sensitizes cells to TRAIL-induced apoptosis by induction of p21waf1/cip1. Therefore, pioglitazone can be an effective therapeutic adjuvant for the treatment of carcinoid tumors. Copyright 2001 S. Karger AG, Basel
BACKGROUND/AIMS: We investigated the effect of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist pioglitazone on growth and TRAIL-induced apoptosis in carcinoid cells. METHODS: Carcinoid cells were incubated without and with pioglitazone. Effects on growth were examined by cell count and cell cycle analysis. p21waf1/cip1 expression was determined by Western blotting. Cytotoxicity assay was performed by FACS analysis. RESULTS:Pioglitazone suppressed the growth and induced apoptosis of carcinoid cells. Additionally, pioglitazone significantly enhanced carcinoid cell death induced by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL). The enhancement of TRAIL-induced apoptosis was associated with an upregulation of cyclin-dependent kinase inhibitor p21waf1/cip1 in pioglitazone-treated carcinoid cells. Importantly, overexpression of p21waf1/cip1 in carcinoid cells by adenoviral gene transfer of p21 sensitized them to TRAIL-induced apoptosis. CONCLUSIONS: These results suggest that pioglitazone inhibits cell growth and sensitizes cells to TRAIL-induced apoptosis by induction of p21waf1/cip1. Therefore, pioglitazone can be an effective therapeutic adjuvant for the treatment of carcinoid tumors. Copyright 2001 S. Karger AG, Basel
Authors: Koen M A Dreijerink; Radhika A Varier; Olivier van Beekum; Ellen H Jeninga; Jo W M Höppener; Cornelis J M Lips; J Alain Kummer; Eric Kalkhoven; H T Marc Timmers Journal: Mol Cell Biol Date: 2009-07-13 Impact factor: 4.272
Authors: Robert J George; Mark A Sturmoski; Randal May; Sripathi M Sureban; Brian K Dieckgraefe; Shrikant Anant; Courtney W Houchen Journal: Am J Physiol Gastrointest Liver Physiol Date: 2008-12-04 Impact factor: 4.052
Authors: Thomas S Griffith; Brittany Stokes; Tamara A Kucaba; James K Earel; Rebecca L VanOosten; Erik L Brincks; Lyse A Norian Journal: Curr Gene Ther Date: 2009-02 Impact factor: 4.391
Authors: Michael J Pishvaian; John L Marshall; Andrew J Wagner; Jimmy J Hwang; Shakun Malik; Ion Cotarla; John F Deeken; A Ruth He; Hirut Daniel; Abdel-Baset Halim; Hamim Zahir; Catherine Copigneaux; Kejian Liu; Robert A Beckman; George D Demetri Journal: Cancer Date: 2012-05-08 Impact factor: 6.860
Authors: Jessica Castro; Marc Ribó; Susanna Navarro; Maria Victòria Nogués; Maria Vilanova; Antoni Benito Journal: BMC Cancer Date: 2011-01-11 Impact factor: 4.430